ID: ALA555332

Max Phase: Preclinical

Molecular Formula: C10H13ClFN

Molecular Weight: 165.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(/C(=C\F)CN)cc1.Cl

Standard InChI:  InChI=1S/C10H12FN.ClH/c1-8-2-4-9(5-3-8)10(6-11)7-12;/h2-6H,7,12H2,1H3;1H/b10-6-;

Standard InChI Key:  ITJUWDAETIBPPZ-OTUCAILMSA-N

Associated Targets(non-human)

Monoamine oxidase 439 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 165.21Molecular Weight (Monoisotopic): 165.0954AlogP: 2.26#Rotatable Bonds: 2
Polar Surface Area: 26.02Molecular Species: BASEHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.12CX LogP: 1.99CX LogD: 0.28
Aromatic Rings: 1Heavy Atoms: 12QED Weighted: 0.71Np Likeness Score: -0.57

References

1. McDonald IA, Lacoste JM, Bey P, Palfreyman MG, Zreika M..  (1985)  Enzyme-activated irreversible inhibitors of monoamine oxidase: phenylallylamine structure-activity relationships.,  28  (2): [PMID:3968682] [10.1021/jm00380a007]

Source